CAR-T Cell Immunotherapy ProgramCAR-T细胞免疫治疗项目
CAR-T细胞免疫治疗项目CAR-T Cell Immunotherapy Program
An advanced cellular immunotherapy program that utilizes genetically engineered T cells, manufactured via verified transfection platforms, to target and destroy hematologic and specific solid tumor malignancies.一种先进的细胞免疫治疗，利用通过特定转染平台制备的基因工程T细胞，靶向并破坏血液系统及部分实体瘤恶性肿瘤细胞。
Delivering hospital交付医院
An advanced cellular therapy hospital in Beidaihe, specializing in immune cell storage, non-viral CAR-T cell trials, and precision oncology.位于北戴河的先进细胞治疗医院，专注于免疫细胞存储、非病毒CAR-T细胞临床试验及精准肿瘤治疗。
Regulatory basis监管依据
NMPA clinical trial approval (CD19 non-viral CAR-T cell injection BZ019, April 2019).NMPA 临床试验批件（CD19 非病毒载体 CAR-T 细胞注射液 BZ019，2019年4月）。
Cost费用说明
Uwell Cloud does not publish a figure for medical treatment. The hospital quotes the clinical cost after pre-screening and bills you directly — Uwell Cloud never collects medical fees. Uwell Cloud's own coordination fee is published in full on the service-packages page.优健云不公布医疗费用金额。临床费用由医院在预筛后报价并直接向患者结算，优健云不代收任何医疗费用。优健云自身的服务协调费已在服务套餐页完整公示。